Tag:
apremilast
Latest Headlines
Latest Headlines
Celgene touts pipeline, stem cell drug at R&D day
At its R&D day yesterday, Celgene said that it expects to see $6 billion in revenue by 2015 from its three big blood cancer drugs Revlimid, Thalomid and Vidaza. But beyond its marketed products,
